Oral semaglutide 25 mg (Wegovy pill) , FDA-approved December 22, 2025, is the first oral GLP-1 approved for chronic weight management
They fill their prescription
This includes maintaining the body weight (BW), blood glucose level, cardiovascular system (CVS) risk, complexity, and co-morbidities
How to structure small, simple meals and handle nausea, constipation and reflux with a side-effect food playbook
Reduce the risk of Alzheimers & Parkinsons disease Enhance brain cell survival & repair Improve memory & cognitive function Because GLP-1 reduces inflammation and oxidative stress in the brain , scientists are even studying its potential role in treating dementia and cognitive decline
Kario K, Wang JG, Chia YC, Wang TD, Li Y, Siddique S, et al